<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T04:18:00Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/130991" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/130991</identifier><datestamp>2025-12-04T20:39:03Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478800</setSpec><setSpec>col_2072_478858</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:Item id="hdl_2445_130991">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:2445/130991</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer</dc:title>
               <dc:creator>Navarro Ponz, Alfons</dc:creator>
               <dc:creator>Moisés, Jorge</dc:creator>
               <dc:creator>Santasusagna, Sandra</dc:creator>
               <dc:creator>Marrades Sicart, Ramon Ma.</dc:creator>
               <dc:creator>Viñolas Segarra, Núria</dc:creator>
               <dc:creator>Castellano, Joan Josep</dc:creator>
               <dc:creator>Canals, Jordi</dc:creator>
               <dc:creator>Muñoz García, Carmen</dc:creator>
               <dc:creator>Ramirez, José</dc:creator>
               <dc:creator>Molins López-Rodó, Laureano</dc:creator>
               <dc:creator>Monzó Planella, Mariano</dc:creator>
               <dc:subject>Càncer de pulmó</dc:subject>
               <dc:subject>RNA</dc:subject>
               <dc:subject>Lung cancer</dc:subject>
               <dc:subject>RNA</dc:subject>
               <dc:description>Background HOTTIP, a long non-coding RNA located in the HOXA cluster, plays a role in the patterning of tissues with mesodermal components, including the lung. Overexpression of HOXA genes, including HOTTIP, has been associated with a more aggressive phenotype in several cancers. However, the prognostic impact of HOTTIP has not yet been explored in non-small-cell lung cancer (NSCLC). We have correlated HOTTIP expression with time to relapse (TTR) and overall survival (OS) in early-stage NSCLC patients. Methods Ninety-nine early-stage NSCLC patients who underwent surgical resection in our center from June 2007 to November 2013 were included in the study. Mean age was 66; 77.8% were males; 73.7% had stage I disease; and 55.5% had adenocarcinoma. A validation data set comprised stage I-II patients from The Cancer Genome Atlas (TCGA) Research Network. Results HOTTIP was expressed in all tumor samples and was overexpressed in squamous cell carcinoma (p = 0.007) and in smokers (p = 0.018). Patients with high levels of HOTTIP had shorter TTR (78.3 vs 58 months; p = 0.048) and shorter OS (81.2 vs 61 months; p = 0.023) than those with low levels. In the multivariate analysis, HOTTIP emerged as an independent prognostic marker for TTR (OR: 2.05, 95%CI: 1-4.2; p = 0.05), and for OS (OR: 2.31, 95%CI: 1.04-5.1; p = 0.04). HOTTIP was validated as a prognostic marker for OS in the TCGA adenocarcinoma cohort (p = 0.025). Moreover, we identified a 1203-mRNA and a 61-miRNA signature that correlated with HOTTIP expression. Conclusions The lncRNA HOTTIP can be considered a prognostic biomarker in early-stage NSCLC.</dc:description>
               <dc:date>2019-03-27T18:41:54Z</dc:date>
               <dc:date>2019-03-27T18:41:54Z</dc:date>
               <dc:date>2019-02-28</dc:date>
               <dc:date>2019-03-27T18:41:54Z</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
               <dc:relation>Reproducció del document publicat a: https://doi.org/10.1186/s12890-019-0816-8</dc:relation>
               <dc:relation>BMC Pulmonary Medicine, 2019, vol. 19, num. 1, p. 55-63</dc:relation>
               <dc:relation>https://doi.org/10.1186/s12890-019-0816-8</dc:relation>
               <dc:rights>cc-by (c) Navarro Ponz, Alfons et al., 2019</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by/3.0/es</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>BioMed Central</dc:publisher>
               <dc:source>Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>